The director of the Pharmacy and Associate Medicine Department at SEHA, Dr. Zain Al-Yafi, confirmed that the nearly 900 pharmacists in various SEHA facilities, and in isolation hospitals and field hospitals, provide high-quality pharmaceutical services in pharmacy and clinical pharmacy in all systems. Health care in SEHA facilities.
He said that the pharmaceutical cadres play an essential role within the medical treatment team, and are keen to provide medicines and necessary treatment for patients according to the treatment protocol adopted in the country and in cooperation with a group of doctors, as pharmacists and clinical pharmacists have a vital role in determining the best medications used for medical conditions and their interactions, and checking doses Medication, which contributes to enhancing the solidarity between doctors and pharmacists to achieve the best treatment and medication plans for the patient, which contributes to the speedy recovery of patients, and reduces the period of their stay in the hospital or intensive care centers. He added that “SEHA” provides an opportunity for pharmacists to apply expertise on the most important findings of research and scientific studies, and the latest developments in the field of pharmaceutical care from the administration of drug therapy and drug safety.
He pointed out that the application of the company «Health» smart pharmacy in most of its facilities, contributed to achieving important results in terms of the accuracy of dispensing drugs, reducing the waiting period and the absence of medication errors, as the number of drugs that were dispensed reached about two million drugs since the beginning of this year, while Delivery of medicines to re-dispensed prescriptions and telemedicine prescriptions for 40,000 patients, in cooperation with a distribution company, since the beginning of the Medicines Delivery Initiative last March. He continued that the pharmaceutical staff plays the full role in the service of delivering medicines to the home, following up with patients remotely and the continuity of drug education in a way that guarantees the safety of patients and providing the pharmaceutical service according to international standards even under the Corona pandemic.